Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Geneva, IL
NPI: 1235143835Primary Practice Location
NORTHWESTERN MEDICINE DELNOR COMMUNITY HOSPITAL
300 Randall Rd, Geneva, IL
Primary Employer
Northwestern Medical Group
nm.org
HQ Phone
Get M.D. Christopher's Phone Numberphone_androidMobile
Get M.D. Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 200 | 584 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 77 | 79 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 65 | 102 |
| 4 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 54 | 75 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 39 | 49 |
Web-Based Cancer Symptom Self-Management System: A Randomized Clinical Trial.
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Placebo, DRUG: Dexamethasone, DRUG: Olanzapine, DRUG: Palonosetron Hydrochloride, DRUG: Ondansetron Hydrochloride, DRUG: Fosaprepitant Dimeglumine
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Prednisone, DRUG: Antiandrogen Therapy, DRUG: Cabazitaxel, DRUG: Abiraterone Acetate, PROCEDURE: Orchiectomy
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebo, DRUG: Cabozantinib, DRUG: CB-839
